J. Yarnold

发表

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

D. Dearnaley, A. Horwich, V. Khoo, 1999, The Lancet.

Homologous recombination mediates cellular resistance and fraction size sensitivity to radiation therapy.

J. Yarnold, T. Helleday, N. Somaiah, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Relationship Between Homologous Recombination Repair and the Sensitivity of Human Epidermis to the Size of Daily Doses Over a 5-Week Course of Breast Radiotherapy

J. Yarnold, T. Helleday, N. Somaiah, 2012, Clinical Cancer Research.

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.

M. Sydes, D. Dearnaley, P. Pharoah, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.

J. Yarnold, I. Smith, H. Ford, 1985, Cancer treatment reports.

The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity

J. Yarnold, R. A’Hern, J. Bliss, 1995 .

Correlation of breast dose heterogeneity with breast size using 3D CT planning and dose-volume histograms

J. Yarnold, A. Neal, M. Torr, 1995 .

Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.

Petra Seibold, Frederik Wenz, Alison M Dunning, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Petra Seibold, Hubert Thierens, Alison M Dunning, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer.

Mechthild Krause, Meritxell Arenas, Marianne C Aznar, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioning.

N. Aaronson, J. Yarnold, M. Broderick, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments.

J R Yarnold, N K Aaronson, N. Aaronson, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation in the context of multidisciplinary approaches: radiotherapy and locally advanced breast cancer

J. Yarnold, 2001 .

Design of compensators for breast radiotherapy using electronic portal imaging.

W P Mayles, P M Evans, W Swindell, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality assurance in daily treatment procedure: patient movement during tangential fields treatment.

C Westbrook, J. Yarnold, J Yarnold, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial

J. Yarnold, L. Gothard, M. Glover, 2016, The Lancet. Oncology.

Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy

J. Yarnold, L. Gothard, J. Haviland, 2014, Radiation oncology.

Radiation fibrosis--current clinical and therapeutic perspectives.

J. Yarnold, C. Westbury, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy.

D. Tait, J. Yarnold, L. Gothard, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Mixing anthracyclines and radiotherapy in early breast cancer: how safe is it?

J. Yarnold, P. Hjiyiannakis, 1996, European journal of cancer.

Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.

Roger Owen, J. Yarnold, S. Bentzen, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Accelerated partial breast irradiation trials: diversity in rationale and design.

J. Yarnold, M. Mannino, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question!

J. Yarnold, S. Bentzen, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials.

H. Bartelink, P. Evans, J. Yarnold, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Postmastectomy radiotherapy: questions for the twenty-first century.

H. Bartelink, A. Recht, J. Yarnold, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Post-mastectomy radiotherapy: is it cure after all?

J. Yarnold, S. Jefferies, 1994, European journal of cancer.

Cellular radiosensitivity and DNA damage in primary human fibroblasts.

J. Yarnold, R. Wurm, J. Peacock, 1994, International journal of radiation oncology, biology, physics.

A multicentre study of the evidence for customized margins in photon breast boost radiotherapy

P. Evans, J. Yarnold, C. Coles, 2015, The British journal of radiology.

Benefits expected from simple conformal radiotherapy in the treatment of pelvic tumours.

A. Nahum, D. Tait, J. Yarnold, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.

P. Ellis, A. Harris, M. Sculpher, 2011, European journal of cancer.

Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.

H. Earl, J. Peto, J. Yarnold, 2007, Journal of the National Cancer Institute.

TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer.

J. Yarnold, J. Overgaard, J. Alsner, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Molecular Biology for Oncologists

M. Stratton, J. Yarnold, T. McMillan, 1993 .

Molecular aspects of cellular responses to radiotherapy.

J. Yarnold, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Increased collagen production in fibroblasts cultured from irradiated skin and effect of TGF β1– clinical study

J. Yarnold, M. Illsley, J. Yarnold, 2000, British Journal of Cancer.

Correlation of breast dose heterogeneity with breast size using 3D CT planning and dose-volume histograms.

J. Yarnold, A. Neal, M. Torr, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Localising the tumour bed in breast radiotherapy.

J. Yarnold, C. Coles, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Tumor bed delineation for partial breast and breast boost radiotherapy planned in the prone position: what does MRI add to X-ray CT localization of titanium clips placed in the excision cavity wall?

P. Evans, J. Yarnold, N. deSouza, 2009, International journal of radiation oncology, biology, physics.

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

J. Yarnold, J. Dewar, P. Hoskin, 2008, The Lancet. Oncology.

Evaluation of compensation in breast radiotherapy: a planning study using multiple static fields.

P M Evans, E M Donovan, J R Yarnold, 2000, International journal of radiation oncology, biology, physics.

Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial.

J. Yarnold, Y. Tsang, K. Venables, 2012, The British journal of radiology.

An investigation into methods of IMRT planning applied to breast radiotherapy.

P. Evans, J. Yarnold, E. Adams, 2008, The British journal of radiology.

Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues.

J. Yarnold, N. Somaiah, J. Bliss, 2015, Breast.

Benefits of post-mastectomy radiotherapy

J. Yarnold, 1997, The Lancet.

Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials

J. Yarnold, C. Griffin, J. Haviland, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries.

J. Yarnold, J. Haviland, J. Bliss, 2011, International journal of radiation oncology, biology, physics.

Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology).

H. Bartelink, J. Yarnold, B. Mijnheer, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intraoperative Radiotherapy: Is it Ready for Prime Time?

J. Yarnold, A. Thompson, 2015, Current Breast Cancer Reports.

From 25 Fractions to Five: How Hypofractionation has Revolutionised Adjuvant Breast Radiotherapy.

J. Yarnold, N. Somaiah, A. Kirby, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

I. Ellis, P. Evans, M. Sculpher, 2017, The Lancet.

Correlation between DNA damage responses of skin to a test dose of radiation and late adverse effects of earlier breast radiotherapy.

J. Yarnold, M. Chua, S. Bourne, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation.

J. Yarnold, S. Bentzen, J. Haviland, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

United Kingdom Experience: Clinical Trial Evolution, Techniques, Data, and Toxicity

J. Yarnold, N. Somaiah, 2016 .

DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy

J. Yarnold, M. Chua, R. A’Hern, 2014, Radiation and environmental biophysics.

E13. Hypofractionated radiotherapy for breast cancer

J. Yarnold, 2012 .

Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy.

J. Yarnold, M. Chua, R. A’Hern, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial).

J. Yarnold, C. Coles, J. Fairfoul, 2011, International journal of radiation oncology, biology, physics.

Quality of life after breast radiotherapy – Authors' reply

J. Yarnold, J. Haviland, J. Bliss, 2010 .

Test of association between variant tgβ1 alleles and late adverse effects of breast radiotherapy.

J. Yarnold, R. A’Hern, J. Haviland, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reports of unexpected late side effects of accelerated partial breast irradiation--radiobiological considerations.

J. Yarnold, S. Bentzen, 2010, International journal of radiation oncology, biology, physics.

Radiotherapy Delivery for Women with Early Breast Cancer

J. Yarnold, 2010 .

Pushing the limits of hypofractionation for adjuvant whole breast radiotherapy.

J. Yarnold, J. Haviland, 2010, Breast.

Radiotherapy hypofractionation in early breast cancer – Author's reply

J. Yarnold, 2008, The Lancet.

Hypofractionated whole breast irradiation

J. Yarnold, 2008 .

Dose and fractionation regimens for breast cancer – Authors' reply

J. Yarnold, S. Bentzen, J. Haviland, 2006 .

Fractionation in radiotherapy: results of a Canadian randomised clinical trial

J. Yarnold, 2005 .

Selective avoidance of lymphatic radiotherapy in the conservative management of women with early breast cancer.

J. Yarnold, S. Ebbs, L. Gothard, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

19 Fractionation sensitivity of breast cancer. Results of a randomised trial

J. Yarnold, S. Bentzen, J. Bliss, 2003 .

Magnetic resonance imaging of induration in the irradiated breast.

A. Padhani, J. Yarnold, J. Husband, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

J. Yarnold, C. Coles, N. Somaiah, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment

A. Rust, J. Yarnold, K. Fenwick, 2018, Breast Cancer Research and Treatment.

High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma

J. Yarnold, I. Smith, H. Ford, 2004, Cancer Chemotherapy and Pharmacology.

Intratumoural hydrogen peroxide with radiotherapy in locally advanced breast cancer: results from a Phase I clinical trial.

E. Sawyer, D. Tait, J. Yarnold, 2020, International journal of radiation oncology, biology, physics.

Radiotherapy for breast cancer, the TARGIT-A trial

R. Sarin, J. Yarnold, I. Olivotto, 2014, The Lancet.

What are cancer genes, and how do they upset cell behaviour?

J. Yarnold, John R Yarnold, 1992, European journal of cancer.

Breast radiotherapy and heart disease - where are we now?

J. Yarnold, A. Kirby, F. Bartlett, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

HeartSpare Study ( Stage IB ) : Randomised comparison of the voluntary breath-hold technique and prone treatment in larger-breasted women

P. Evans, J. Yarnold, I. Locke, 2015 .

The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery.

P. Evans, J. Yarnold, I. Locke, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The UK HeartSpare Study (Stage II): Multicentre Evaluation of a Voluntary Breath-hold Technique in Patients Receiving Breast Radiotherapy.

P. Evans, J. Yarnold, C. Griffin, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

ESTRO consensus guidelines ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer

L. Boersma, J. Yarnold, V. Remouchamps, 2015 .

E06. Regional control matters in breast cancer

J. Yarnold, B. Offersen, 2014 .

E1. Research progress and priorities in breast radiotherapy

J. Yarnold, 2010 .

Radiotherapy following excision of early breast cancer

J. Yarnold, 2009 .

Simulation of a radiobiology facility for the Centre for the Clinical Application of Particles.

J. Yarnold, V. Blackmore, K. Long, 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Role of radiotherapy in the management of bone metastases from breast cancer.

J. Yarnold, 1985, Journal of the Royal Society of Medicine.

The effectiveness of the routine clinic visit in the follow-up of breast cancer patients: analysis of a defined patient cohort.

J. Yarnold, S. Ebbs, J. Bliss, 1998, Clinical oncology (Royal College of Radiologists (Great Britain)).

A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain.

J. Yarnold, P. Price, J. Regan, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

H. Earl, D. Rea, J. Yarnold, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Status of hypofractionated radiotherapy in breast cancer

J. Yarnold, 2005 .

Latest developments in local treatment: radiotherapy for early breast cancer.

J. Yarnold, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity.

J. Yarnold, R. A’Hern, J. Bliss, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Factors affecting relapse following chemotherapy for Hodgkin's disease.

J. Yarnold, A. Jelliffe, G. Hudson, 1982, Clinical radiology.

Radiotherapy for bone metastasis are single and multiple fractions equivalent

J. Yarnold, J. Regan, P. Hoskin, 1993 .

Minimising oncological treatment of early breast cancer

J. Yarnold, 2008, Breast Cancer Research.

Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery – audit on behalf of the IMPORT Trial Management Group

J. Yarnold, C. Coles, G. Wishart, 2008 .

Session 10: Radiotherapy: Innovation and long term effects in early breast cancer

T. Whelan, J. Yarnold, 2015 .

Haste makes waste: Are the data regarding TARGIT-A IORT ready for prime time?

J. Yarnold, R. Audisio, J. Haviland, 2014, Breast Cancer Research and Treatment.

Is current evidence about intraoperative partial breast irradiation sufficient for broad implementation in clinical practice?

J. Yarnold, P. Poortmans, B. Offersen, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Abstract S4-1: The UK START (Standardisation of Breast Radiotherapy) Trials: 10-year follow-up results

J. Yarnold, J. Dewar, P. Hoskin, 2012 .

Breast conservation and management of early breast cancer.

J. Yarnold, 1990, European journal of cancer.

Patterns of breast relapse after local excision +/- radiotherapy for early stage breast cancer.

J. Yarnold, P. Price, G. Walsh, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.

J. Yarnold, I. Smith, H. Ford, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estimating the volume of lung irradiated during tangential breast irradiation using the central lung distance.

J. Yarnold, A. Neal, 1995, The British journal of radiology.

Morbidity of cranial relapse in small cell lung cancer and the impact of radiation therapy.

J. Yarnold, P. Hoskin, I. Smith, 1986, Cancer treatment reports.

Carboplatin (JM8), etoposide (VP16) and thoracic irradiation for small cell lung cancer (S.C.L.C.): an evaluation of lung toxicity.

J. Yarnold, I. Smith, G. Cherryman, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for cancer.

J. Yarnold, G. Cook, N. Somaiah, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Selective avoidance of lymphatic irradiation in the conservative management of breast cancer.

J. Yarnold, 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A toast to the silver anniversary of Clinical Oncology: a quarter of a century of advances in evidence-based radiation dose fractionation.

J. Yarnold, S. Bentzen, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

The IMPORT trials are launched (September 2006).

J. Yarnold, C. Coles, John Yarnold, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015)

J. Yarnold, J. Haviland, J. Bliss, 2018, International Journal of Radiation Oncology, Biology, Physics.

Targeted Intraoperative Radiotherapy for Early Breast Cancer.

J. Yarnold, S. Bentzen, J. Haviland, 2020, JAMA oncology.

In Regard to Vaidya et al.

J. Yarnold, S. Bentzen, 2015, International journal of radiation oncology, biology, physics.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1.

Mechthild Krause, Meritxell Arenas, Marianne C Aznar, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

How does knowledge of three-dimensional excision margins following breast conservation surgery impact upon clinical target volume definition for partial-breast radiotherapy?

P. Evans, J. Yarnold, E. Harris, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

OC-0595: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy:3-year normal tissue effects

E. Sawyer, J. Yarnold, C. Coles, 2018 .

CNS relapse despite prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC).

J. Yarnold, P. Hoskin, I. Smith, 1986, International journal of radiation oncology, biology, physics.

Intensity-modulated Radiotherapy for the Treatment of Breast Cancer.

J. Yarnold, C. Coles, J. Haviland, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

The use of ultrasound to measure breast thickness to select electron energies for breast boost radiotherapy.

J. Yarnold, J. Hendry, D. Gilligan, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality assurance in conservative treatment of early breast cancer, a consensus meeting. December 13-14, 1990, Tübingen, Germany.

H. Bartelink, J. Yarnold, B. Mijnheer, 1991, Radiotherapy and Oncology.

Target volume definition for external beam partial breast radiotherapy: clinical, pathological and technical studies informing current approaches.

J. Yarnold, C. Coles, A. Kirby, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

P15 The IMPORT Gold Seed Study: Evaluation of Tumour Bed Localisation and Image-guided Radiotherapy for Breast Cancer

J. Yarnold, C. Coles, G. Wishart, 2007 .

OUTCOME INDICATORS FOR BREAST CANCER

R. Blamey, R. Priestley, J. Yarnold, 1999 .

Multileaf collimation cardiac shielding in breast radiotherapy: Cardiac doses are reduced, but at what cost?

P. Evans, J. Yarnold, I. Locke, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis

R. Faria, J. Yarnold, C. Coles, 2022, Breast Cancer Research and Treatment.

Measurement of Human Normal Tissue and Tumour Responses

J. Yarnold, G. Ross, 1988 .

Intercalated radio-chemotherapy in small cell lung cancer: toxicity and implications for future regimens.

J. Yarnold, P. Hoskin, I. Smith, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?

J. Yarnold, M. Mannino, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer.

D. Easton, R. Coombes, J. Yarnold, 1987, Cancer research.

Assessing breast cosmesis after radiotherapy: what do we want to measure?

J. Yarnold, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Study design in the evaluation of combined radiotherapy plus chemotherapy.

J. Yarnold, P. Hoskin, S. Powell, 1990, European journal of cancer.

DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy

J. Yarnold, M. Chua, R. A’Hern, 2014, Radiation and Environmental Biophysics.

8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-upOn behalf of the Bone Pain Trial Working Party

J. Yarnold, 1999 .

Pathogenetic mechanisms in radiation fibrosis.

J. Yarnold, John Yarnold, Marie-Catherine Vozenin Brotons, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique

H. Bartelink, P. Evans, J. Yarnold, 2014 .

Dynamic MRI of breast hardness following radiation treatment

A. Padhani, J. Yarnold, J. Husband, 2003, Journal of magnetic resonance imaging : JMRI.

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Bingshu E. Chen, D. Berry, P. Fasching, 2019, The Lancet.

The surgical treatment of radiation injuries after radiotherapy for uterine carcinoma

W. W. Slack, J. Yarnold, J. Cochrane, 1981, The British journal of surgery.

Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: the PPALM study.

J. Yarnold, L. Gothard, J. Bliss, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Joanne S Haviland, John R Yarnold, J. Yarnold, 2013, The Lancet. Oncology.

The UK HeartSpare Study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy.

Philip M Evans, Joanne S Haviland, John R Yarnold, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells

P. Jeggo, K. Harrington, J. Yarnold, 2021, Scientific Reports.

Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy.

S. Underwood, J. Yarnold, B. Seddon, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Selective avoidance of lymphatic radiotherapy in the conservative management of early breast cancer.

D. Tait, J. Yarnold, S. Ebbs, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

J R Yarnold, J. Yarnold, J. Dewar, 2008, The Lancet.

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial

D. Girling, R. Stephens, A. Gregor, 1997 .

Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.

J. Yarnold, P. Price, P. Hoskin, 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Acute Chemotherapy–Related Toxicity Is Not Increased in BRCA1 and BRCA2 Mutation Carriers Treated for Breast Cancer in the United Kingdom

A. Howell, R. Eeles, D. Easton, 2006, Clinical Cancer Research.

Targeted radiotherapy for early breast cancer – Authors' reply

J. Yarnold, C. Coles, M. Wilcox, 2018, The Lancet.

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.

J. Yarnold, J. Haviland, J. Bliss, 2010, The Lancet. Oncology.

Early and locally advanced breast cancer: diagnosis and treatment National Institute for Health and Clinical Excellence guideline 2009.

J. Yarnold, J Yarnold, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules.

J. Yarnold, R. Wurm, J. Peacock, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules

J. Yarnold, R. Wurm, J. Peacock, 1994 .

Comparison between pulsed-field gel electrophoresis and the comet assay as predictive assays for radiosensitivity in fibroblasts.

J. Sarkaria, J. Yarnold, J. Peacock, 1998, Radiation research.

Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.

J. Yarnold, L. Gothard, E. Hall, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Modulation of late adverse effects of curative radiation therapy for cancer (Chapter 17)

J. Yarnold, L. Gothard, 2004 .

Multicentric breast cancer: clonality and prognostic studies

R. Eeles, S. Jhavar, J. Bartek, 2011, Breast Cancer Research and Treatment.

Consensus document on staging for breast cancer

J. Yarnold, J. Dixon, M. Greco, 1994 .

Cellular radiosensitivity and complication risk after curative radiotherapy.

J. Yarnold, J. Eady, J. Peacock, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Transforming growth factor beta: relevance to radiotherapy.

C. Parker, J. Yarnold, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiobiology of breast cancer.

A. Tutt, J. Yarnold, Andrew Tutt, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Changes in mast cell number and stem cell factor expression in human skin after radiotherapy for breast cancer.

A. Freeman, J. Yarnold, A. Pearson, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Correlation between the radiation responses of fibroblasts cultured from individual patients and the risk of late reaction after breast radiotherapy.

J. Yarnold, M. Chua, N. Somaiah, 2016, Cancer letters.

Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity

R. Wurm, J. Yarnold, R. Wurm, 1992, The Lancet.

Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial.

John R Yarnold, J. Yarnold, S. Bentzen, 2006, The Lancet. Oncology.

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

I. Ellis, M. Dowsett, P. Ellis, 2009, The Lancet.

Genome‐wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c‐Kit, CD117) and oestrogen receptor‐α (ERα) in response to therapeutic radiation

A. Ashworth, J. Reis-Filho, C. Isacke, 2009, The Journal of pathology.

Abstract P1-13-03: Mature analysis of UK Taxotere as Adjuvant Chemotherapy (TACT) trial (CRUK 01/001); effects of treatment and characterisation of patterns of breast cancer relapse.

M. Dowsett, H. Earl, J. Yarnold, 2012 .

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

E. Sawyer, J. Yarnold, C. Coles, 2020, The Lancet.

Abstract GS4-05: Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK/06/003)

J. Yarnold, C. Coles, M. Wilcox, 2019, General Session Abstracts.

Does participation in clinical trials influence the implementation of new techniques? A look at changing techniques in breast radiotherapy in the UK.

J. Yarnold, C. Coles, Y. Tsang, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Late Toxicity Is Not Increased in BRCA1/BRCA2 Mutation Carriers Undergoing Breast Radiotherapy in the United Kingdom

A. Howell, R. Eeles, D. Easton, 2006, Clinical Cancer Research.

Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.

Richard Symonds-Tayler, Diana Tait, D. Tait, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

J. Yarnold, J. Haviland, J. Bliss, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial

J. Yarnold, C. Coles, C. Kirwan, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities.

J. Yarnold, C. Coles, S. Bentzen, 2011, International journal of radiation oncology, biology, physics.

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S Michiels, B Asselain, J Bogaerts, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Malignant melanoma: significance of disease-free interval.

J. Yarnold, J. Cochrane, 1980, The British journal of radiology.

Management of Radiation Injuries to the Bowel Associated with Treatment of Uterine Carcinoma by Radiotherapy: Preliminary Communication

J. Yarnold, J. Cochrane, 1979, Journal of the Royal Society of Medicine.

The treatment of carcinoma of the cervix and endometrium using the cathetron at the Middlesex Hospital.

J. Yarnold, H. Lambert, M. Snelling, 1979, Clinical radiology.

Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer.

P. Evans, J. Yarnold, E. Donovan, 2012, Medical physics.

Where Do We Look for Markers of Radiotherapy Fraction Size Sensitivity?

J. Yarnold, N. Somaiah, K. Rothkamm, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Variation in the manganese superoxide dismutase gene (SOD2) is not a major cause of radiotherapy complications in breast cancer patients.

R. Houlston, J. Yarnold, J. Peacock, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

How Low Can You Go? The Radiobiology of Hypofractionation.

J. Yarnold, N. Somaiah, A. Kirby, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.

J. Chang-Claude, J. Debus, A. Dunning, 2015, International journal of radiation oncology, biology, physics.

Establishment of a Radiogenomics Consortium.

Andrzej Polanski, Karin Haustermans, Barry Rosenstein, 2010, International journal of radiation oncology, biology, physics.

Conducting radiogenomic research--do not forget careful consideration of the clinical data.

Johannes A Langendijk, Clare Griffin, Dirk De Ruysscher, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer.

Christophe Badie, Simon Bouffler, Roger Owen, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5,456 breast and prostate cancer patients

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

ATM rs1801516 SNP and toxicity after radiotherapy

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity

P. Pharoah, A. Dunning, K. Michailidou, 2015, Clinical Cancer Research.

Breast radiotherapy: less is more?

J. Yarnold, C. Coles, A. Brunt, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Effect of breast-duct anatomy and wound-healing responses on local tumour recurrence after primary surgery for early breast cancer.

J. Yarnold, M. Mannino, 2009, The Lancet. Oncology.

Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?

M. J. van de Vijver, J. Yarnold, I. Kunkler, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

J. Yarnold, J. Haviland, J. Bliss, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy.

V. P. Misra, P. Anand, J. Yarnold, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer.

J. Yarnold, J. Risdall, L. Gothard, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration.

J. Yarnold, A. Pearson, L. Gothard, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin.

Kai Rothkamm, Frances Daley, Roger Owen, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

P. Evans, J. Yarnold, I. Locke, 2014, Journal of visualized experiments : JoVE.

Characterization of target volume changes during breast radiotherapy using implanted fiducial markers and portal imaging.

Emma J Harris, Philip M Evans, John R Yarnold, 2009, International journal of radiation oncology, biology, physics.

Weight gain after primary surgery for breast cancer - effect of tamoxifen

Sue Ashley, J. Yarnold, P. Hoskin, 2005, Breast Cancer Research and Treatment.

Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

M. Gore, J. Yarnold, I. Smith, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The delivery of intensity modulated radiotherapy to the breast using multiple static fields.

M Partridge, P M Evans, E M Donovan, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluation of implanted gold seeds for breast radiotherapy planning and on treatment verification: a feasibility study on behalf of the IMPORT trialists.

Sarah L Vowler, Emma J Harris, Philip M Evans, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation.

J. Yarnold, N. Somaiah, A. Kirby, 2021, Clinics in oncology.

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.

John R Yarnold, Laura Ciurlionis, J. Yarnold, 2015, The British journal of radiology.

Radiotherapy for bone metastases.

J. Yarnold, S. Bentzen, P. Hoskin, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Ductal carcinoma in situ of the breast

J. Yarnold, N. Bundred, N. Barnes, 2012, BMJ : British Medical Journal.

Reply to Goodare et al. Re: Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy?

J. Yarnold, M. Wilcox, J. Haviland, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial

J. Yarnold, C. Coles, A. Kirby, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT)

I. Ellis, M. Dowsett, P. Ellis, 2009 .

Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?

J. Yarnold, J. Haviland, Y. Tsang, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A randomised trial of supine versus prone breast radiotherapy (SuPr study): comparing set-up errors and respiratory motion.

Philip M Evans, John R Yarnold, P. Evans, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Guidelines for locoregional therapy in primary breast cancer in developing countries: The results of an expert panel at the 8th Annual Women's Cancer Initiative – Tata Memorial Hospital (WCI-TMH) Conference

R. Sarin, J. Yarnold, B. Anderson, 2012, Indian Journal of Medical and Paediatric Oncology.

Ductal Carcinoma in Situ (DCIS) of the breast

J. Yarnold, N. Bundred, John Yarnold, 2012 .

Practical implementation of compensators in breast radiotherapy.

P M Evans, N Fenton, S Reise, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).

H. Wildiers, J. Bogaerts, J. Yarnold, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Modelling the cost-effectiveness of first, second and third generation polychemotherapy regimens in women with early breast cancer who have differing prognoses.

M. Sculpher, H. Earl, J. Yarnold, 2009 .

Shorter fractionation schedules in breast cancer radiotherapy: clinical and economic implications.

J. Yarnold, M. Mannino, 2009, European journal of cancer.

Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer.

D. Tait, J. Yarnold, J. Haviland, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Overview of Hypofractionation in Breast Radiotherapy

J. Yarnold, N. Somaiah, 2011 .

Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry.

Philip M Evans, John R Yarnold, P. Evans, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Linear-Quadratic Model and Implications for Fractionation.

J. Yarnold, D. Brand, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

Joanne S Haviland, John R Yarnold, J. Yarnold, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Bone metastasis consensus statement.

J. Yarnold, P. Blitzer, T. Bates, 1992, International journal of radiation oncology, biology, physics.

Changes in radiotherapy fractionation—breast cancer

J. Yarnold, 2018, The British journal of radiology.

Low dose single fraction radiotherapy in the treatment of metastatic bone pain: a pilot study.

J. Yarnold, P. Price, P. Hoskin, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

E. Sawyer, J. Yarnold, C. Coles, 2023, The Lancet.

Evaluation of a method for grading late photographic change in breast appearance after radiotherapy for early breast cancer.

D. Tait, J. Yarnold, L. Gothard, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

OC-0101 First results of FAST-Forward phase 3 RCT nodal substudy: 3-year normal tissue effects

J. Yarnold, N. Somaiah, J. Haviland, 2022, Radiotherapy and Oncology.

Clinical dosimetry for radiotherapy to the breast based on imaging with the prototype Royal Marsden Hospital CT simulator.

S Webb, M O Leach, J R Yarnold, 1987, Physics in medicine and biology.

Matching supraclavicular fields to the extent of axillary surgery in women prescribed radiotherapy for early stage carcinoma of the breast.

J. Yarnold, G. Ross, P. Wells, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Dose-position and dose-volume histogram analysis of standard wedged and intensity modulated treatments in breast radiotherapy.

P M Evans, E M Donovan, J R Yarnold, 2002, The British journal of radiology.

OC-0135 CAN PATIENT REPORTED OUTCOME MEASURES REPLACE CLINICAL ASSESSMENTS IN BREAST RADIOTHERAPY TRIALS?

J. Yarnold, J. Haviland, J. Bliss, 2012 .

The Use of Compensators and Multiple Static Fields for IMRT of the Breast

P. Evans, D. Convery, J. Yarnold, 2000 .

Improved dose homogeneity in the breast using tissue compensators.

W P Mayles, S Webb, J R Yarnold, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast cancer radiation therapy – Authors' reply

J. Yarnold, J. Haviland, A. Brunt, 2020, The Lancet.

Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancer.

J. Yarnold, J. Hill, S. Morgan, 1986, European journal of cancer & clinical oncology.

Principles and practice of radiotherapy.

John Yarnold, J. Yarnold, John Yarnold, 2001 .

The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy.

J. Yarnold, J. Haviland, Y. Tsang, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypofractionated Adjuvant Whole Breast Radiotherapy: Progress and Prospects

J. Yarnold, J. Haviland, 2010, Acta oncologica.

Randomised comparison of a 13 fraction schedule with a conventional 25 fraction schedule of radiotherapy after local excision of early breast cancer: preliminary analysis

J. Yarnold, J. Bliss, J. Owen, 1993 .

Chemotherapy and radiotherapy for advanced testicular non-seminoma. I. The influence of sequence and timing of drugs and radiation on the appearance of normal tissue damage.

A. Horwich, J. Yarnold, G. Duchesne, 1983, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Lymphatic relapse in women with early breast cancer: a difficult management problem.

J. Yarnold, S. Ebbs, L. Gothard, 1999, European journal of cancer.

Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients

A. Børresen-Dale, C. Isacke, K. Sahlberg, 2011, Radiation oncology.

Hypofractionation for early breast cancer: First results of the UK standardization of breast radiotherapy (START) trials

J. Yarnold, J. Dewar, J. Haviland, 2007 .

Management of breast cancer Refer women to multidisciplinary breast clinics

H. Earl, J. Yarnold, S. Kaye, 1994, BMJ.

Non-surgical Management of Early Breast Cancer in the United Kingdom: Radiotherapy Fractionation Practices

J. Yarnold, G. Steel, P. Price, 1995 .

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

E. Sawyer, J. Yarnold, C. Coles, 2023, The Lancet.

Hypofractionated radiotherapy for breast cancer.

J. Yarnold, S. Bentzen, J. Haviland, 2010, The New England journal of medicine.

Dosimetric evaluation of compensation in radiotherapy of the breast: MLC intensity modulation and physical compensators.

P M Evans, W Swindell, V N Hansen, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Invited review: tangential breast irradiation--rationale and methods for improving dosimetry.

J. Yarnold, A. Neal, W. Mayles, 1994, The British journal of radiology.

Treatment at Brompton Hospital and Royal Marsden Hospital

P. Goldstraw, J. Yarnold, S. Spiro, 1988 .

Radiotherapy for bone pain: is a single fraction good enough? UK Multicentre Bone Pain Trial Collaborators.

J. Yarnold, P. Hoskin, R. Barton, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Patterns of relapse following radiotherapy for Hodgkin's disease.

J. Yarnold, A. Jelliffe, G. Hudson, 1982, Clinical radiology.

patterns of Relapse ttodgkin's Disease following Radiotherapy for

J. Yarnold, A. Jelliffe, G. Hudson, 1982 .

Treatment of breast cancer

J. Yarnold, K. Horgan, C. Holcombe, 1994, The Lancet.

Hyperbaric oxygen therapy for chronic bowel dysfunction after pelvic radiotherapy - Authors' reply.

J. Yarnold, L. Gothard, M. Glover, 2016, The Lancet. Oncology.

PROPHYLACTIC CRANIAL IRRADIATION IN SMALL-CELL LUNG CANCER

J. Yarnold, I. Smith, J. Yarnold, 1985, The Lancet.

Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial).

J. Yarnold, C. Coles, J. Fairfoul, 2011, International journal of radiation oncology, biology, physics.

Tumour growth delay as a clinical endpoint for the measurement of radiation response.

J. Yarnold, J. Bamber, J. Gibbs, 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries.

J. Yarnold, J. Haviland, J. Bliss, 2011, International journal of radiation oncology, biology, physics.

Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride.

J R Yarnold, J. Reis-Filho, J. Yarnold, 2007, The British journal of radiology.

Double-blind randomised phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy. Author's reply

J. Yarnold, 2005 .

The influence of sequence and timing of drugs and radiation on the appearance of normal tissue damage

A. Horwich, J. Yarnold, G. Duchesne, 1983 .

Correlation between the radiation responses of fibroblasts cultured from individual patients and the risk of late reaction after breast radiotherapy.

J. Yarnold, M. Chua, N. Somaiah, 2016, Cancer letters.